(Q38212793)

31 August 2017

Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus (English)

1 reference

31 August 2017

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Emanuela Zappulo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Antonio Riccardo Buonomo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Guglielmo Borgia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Ivan Gentile

1

1 reference

31 August 2017

Emanuela Zappulo

2

1 reference

31 August 2017

Antonio Riccardo Buonomo

3

1 reference

31 August 2017

Guglielmo Borgia

4

1 reference

31 August 2017

20 May 2014

1 reference

Expert Review of Anti-infective Therapy

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

775-782

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Hepatitis B and pregnancy: an underestimated issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Chronic viral hepatitis as a public health issue in the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Association of tattooing and hepatitis C virus infection: a multicenter case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Natural history of acute and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Treating chronic hepatitis B: today and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Surrogate endpoints and non-inferiority trials in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Optimal management of HBV infection during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Hepatitis B in pregnancy: challenges and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Hepatitis C and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Perinatal transmission of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Perinatal transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

A significant sex--but not elective cesarean section--effect on mother-to-child transmission of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Hepatitis C virus in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Hepatitis B virus infection and pregnancy: a practical approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Management of chronic hepatitis B in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

When does mother to child transmission of hepatitis C virus occur?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

A systematic review of the fetal safety of interferon alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Perspectives and challenges of interferon-free therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Spontaneous clearance of hepatitis C virus in vertically infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Spontaneous clearance of hepatitis C virus in vertically infected children: any clue for treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 Genomes Project data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.920254

10.1586/14787210.2014.920254

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840817%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference